Sarissa Capital Acquisiti... (SRSA)
NASDAQ: SRSA
· Real-Time Price · USD
10.05
0.00 (0.00%)
At close: Oct 28, 2022, 9:53 PM
Company Description
Sarissa Capital Acquisition Corp. does not have significant operations.
The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
It intends to identify and acquire a business, which focuses on the healthcare and biopharmaceutical industry.
Sarissa Capital Acquisition Corp. was incorporated in 2020 and is based in Greenwich, Connecticut.
Sarissa Capital Acquisition Corp.
| Country | United States |
| IPO Date | Dec 11, 2020 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | n/a |
Contact Details
Stock Details
| Ticker Symbol | SRSA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001821682 |
| CUSIP Number | |
| ISIN Number | KYG7823W1024 |
| Employer ID | 98-1552641 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. Alexander John Denner Ph.D. | Chairman & Chief Executive Officer |
| Patrice Eadon Bonfiglio | Chief Financial Officer |
| Dr. Odysseas D. Kostas M.D. | Senior Managing Director |
| Mark Anthony DiPaolo Esq. | Senior Managing Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 13, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 13, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 10, 2022 | 15-12G | Filing |
| Oct 28, 2022 | 25-NSE | Filing |
| Oct 07, 2022 | 8-K | Current Report |
| Sep 12, 2022 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 12, 2022 | 10-Q | Quarterly Report |
| Aug 05, 2022 | PRER14A | Filing |